biotuesdays.com

BioTuesdays | The Latest in Healthcare Industry News and Market Report...

Go to biotuesdays.com

Bio Tuesdays. BioTuesdays - offers the latest news on the healthcare industry’s corporate and clinical developments, executive moves and...

Read Biotuesdays.com news digest here: view the latest Bio Tuesdays articles and content updates right away or get to their most visited pages. Biotuesdays.com is not yet rated by Alexa. It seems that Bio Tuesdays content is notably popular in USA, as 47.3% of all users (6.9K visits per month) come from this country. We haven’t detected security issues or inappropriate content on Biotuesdays.com and thus you can safely use it. Biotuesdays.com is hosted with GoDaddy.com, LLC (United States) and its basic language is English.

  • Content verdict: Safe
  • Website availability: Live
  • English language flagLanguage: English
  • Last check:

  • 489

    Visitors daily

  • 489

    Pageviews daily

  • 3

    Google PR

  • N/A

    Alexa rank

Biotuesdays.com news digest

  • 0 days

    Arch scientists publish new data linking cytokine IL-32 to DKD

    Arch Biopartners (TSXV: ARCH; OTCQB: ACHFF) announced a scientific team, led by principal scientist Dr. Justin Chun at the University of Calgary, report in the peer-reviewed journal Inflammation Research that interleukin-32 (IL-32), a novel lipid droplet...

  • 0 days

    PreveCeutical files patent for delivery of CNS-active agents

    PreveCeutical Medical (CSE: PREV; OTCQB: PRVCF) has filed an international patent application for the delivery of CNS-active therapeutic agents covering methods and formulations aimed at addressing treatment challenges in neurological diseases and disorders...

  • 0 days

    Rita Johnson-Greene joins Ocugen as CFO

    Ocugen (NASDAQ: OCGN) has appointed Rita Johnson-Greene as chief financial officer (CFO).
    Ms. Johnson-Greene brings more than 20 years of healthcare experience to the role. Most recently, she served as chief operating officer at the Alliance for Regenerative Medicine where she led operations, finance, and global expansion initiatives....

  • 4 days

    Exicure reports publication highlighting Phase 2 burixafor data showing rapid st...

    Exicure (NASDAQ: XCUR) announced that Annals of Hematology has published results from a Phase 2 clinical study demonstrating rapid stem cell mobilization with burixafor (GPC-100/TG-0054)—a highly selective CXCR4 inhibitor—in patients with multiple myeloma...

Domain history

Web host: GoDaddy.com, LLC
Registrar: GoDaddy.com, LLC
Registrant: Registration Private (Domains By Proxy, LLC)
Updated: December 17, 2025
Expires: December 16, 2026
Created: December 16, 2010

Whois record

Safety scores

Trustworthiness

N/A

Child safety

N/A

Newly added profiles

More projects to check

Sites on this web host